证券记录 · 已归档季度
RYTM
Rhythm Pharmaceuticals, Inc. · Healthcare · Biotechnology
17被追踪持有人
0Δ持有人
22.96M持有股份
$1.45B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -1.6% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +6 | 44.38M | $4.90B | +14 | −7 |
| Q1 2026 | 109 | +6 | 41.83M | $3.64B | +11 | −6 |
| Q4 2025 | 102 | 0 | 43.14M | $4.62B | +3 | −2 |
| Q3 2025 | 20 | +1 | 28.88M | $2.92B | +2 | −2 |
| Q2 2025 | 17 | 0 | 22.96M | $1.45B | +1 | −1 |
| Q1 2025 | 14 | +2 | 11.52M | $610.22M | +2 | — |
| Q4 2024 | 12 | 0 | 11.40M | $638.39M | — | — |
| Q3 2024 | 11 | +3 | 9.71M | $508.75M | +3 | — |
| Q2 2024 | 8 | — | 9.56M | $392.54M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (被动) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | PRIMECAP Management ✦ | 4.88M | -15.7% | $308.24M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 18 | The Vanguard Group ✦ (被动) | 3.59M | — | $226.80M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (被动) | 3.59M | — | $226.80M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (被动) | 3.59M | — | $226.80M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (被动) | 3.59M | — | $226.80M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (被动) | 3.59M | — | $226.80M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Fidelity (FMR) ✦ | 1.95M | — | $123.44M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Fidelity (FMR) ✦ | 1.95M | — | $123.44M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Fidelity (FMR) ✦ | 1.95M | — | $123.44M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 1.95M | — | $123.44M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | State Street Global Advisors ✦ (被动) | 1.91M | -3.2% | $120.54M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 28 | T. Rowe Price ✦ | 1.34M | +11.9% | $84.76M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | T. Rowe Price ✦ | 1.34M | +11.9% | $84.76M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Geode Capital Management ✦ (被动) | 1.31M | +1.9% | $82.87M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Geode Capital Management ✦ (被动) | 1.31M | +1.9% | $82.87M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Marshall Wace ✦ | 376.24K | -29.7% | $23.77M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | Marshall Wace ✦ | 376.24K | -29.7% | $23.77M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | Adage Capital Partners ✦ | 341.00K | 新增 | $21.55M | 0.0% | New | 1 | SEC ↗ |
| 35 | Renaissance Technologies ✦ | 314.89K | +2131.4% | $19.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 36 | Norges Bank ✦ (被动) | 207.39K | -7.2% | $13.10M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | Millennium Management ✦ | 198.11K | -8.9% | $12.52M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 38 | Point72 Asset Management ✦ | 170.83K | +167.6% | $10.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 49.04K | +24.6% | $3.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 49.04K | +24.6% | $3.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 49.04K | +24.6% | $3.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 42 | AQR Capital Management ✦ | 49.04K | +24.6% | $3.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 49.04K | +24.6% | $3.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | D. E. Shaw & Co. ✦ | 24.28K | -71.0% | $1.53M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 45 | D. E. Shaw & Co. ✦ | 24.28K | -71.0% | $1.53M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 46 | Wellington Management ✦ | 22.43K | -4.8% | $1.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 47 | Wellington Management ✦ | 22.43K | -4.8% | $1.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 48 | Wellington Management ✦ | 22.43K | -4.8% | $1.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 49 | Wellington Management ✦ | 22.43K | -4.8% | $1.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 50 | Gotham Asset Management ✦ | 4.85K | +2.1% | $306,535 | 0.0% | ▲ Add | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Adage Capital Partners | $21.55M | 0.0% |
已清仓
| Citadel Advisors | $3.71M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 284 持有人, 72.02M 股份, $6.12B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 13
Garfield Alastair
Officer · 2.01K 股 · $233,031
Aug 13
Garfield Alastair
Officer · 1.56K 股 · $182,170
Aug 13
Garfield Alastair
Officer · 3.40K 股 · $402,167
Aug 13
Garfield Alastair
Officer · 800 股 · $95,335
Aug 13
Lee Jennifer Kayden
Officer · 75.83K 股 · $8.90M
Aug 12
Mazabraud Yann
Officer · 2.30K 股 · $257,138
Aug 12
Mazabraud Yann
Officer · 1.00K 股 · $112,856
Aug 12
Mazabraud Yann
Officer · 3.60K 股 · $413,477
Aug 12
Mazabraud Yann
Officer · 14.57K 股 · $1.68M
Aug 12
Mazabraud Yann
Officer · 18.21K 股 · $2.12M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据